Skip to main content

Peer Review reports

From: Rituximab impedes natural killer cell function in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients: A pilot in vitro investigation

Original Submission
8 Aug 2017 Submitted Original manuscript
11 Oct 2017 Reviewed Reviewer Report - Julio Cesar Morales-Medina
20 Oct 2017 Reviewed Reviewer Report - Usman Tambunan
5 Nov 2017 Reviewed Reviewer Report - Istvan Baczko
22 Nov 2017 Author responded Author comments - Natalie Eaton
Resubmission - Version 2
22 Nov 2017 Submitted Manuscript version 2
29 Nov 2017 Reviewed Reviewer Report - Usman Tambunan
17 Dec 2017 Reviewed Reviewer Report - Istvan Baczko
18 Dec 2017 Reviewed Reviewer Report - Julio Cesar Morales-Medina
4 Feb 2018 Author responded Author comments - Natalie Eaton
Resubmission - Version 3
4 Feb 2018 Submitted Manuscript version 3
18 Feb 2018 Author responded Author comments - Natalie Eaton
Resubmission - Version 4
18 Feb 2018 Submitted Manuscript version 4
Publishing
16 Mar 2018 Editorially accepted
27 Mar 2018 Article published 10.1186/s40360-018-0203-8

You can find further information about peer review here.

Back to article page